JP2007204436A - 発声改良剤および発声改良方法 - Google Patents
発声改良剤および発声改良方法 Download PDFInfo
- Publication number
- JP2007204436A JP2007204436A JP2006025924A JP2006025924A JP2007204436A JP 2007204436 A JP2007204436 A JP 2007204436A JP 2006025924 A JP2006025924 A JP 2006025924A JP 2006025924 A JP2006025924 A JP 2006025924A JP 2007204436 A JP2007204436 A JP 2007204436A
- Authority
- JP
- Japan
- Prior art keywords
- coenzyme
- phonation
- improving
- pitched sound
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 8
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims abstract description 30
- 235000017471 coenzyme Q10 Nutrition 0.000 claims abstract description 30
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical class COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract description 30
- 229940110767 coenzyme Q10 Drugs 0.000 claims abstract description 29
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 11
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 11
- 229940046009 vitamin E Drugs 0.000 claims abstract description 11
- 239000011709 vitamin E Substances 0.000 claims abstract description 11
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 8
- 230000006872 improvement Effects 0.000 claims abstract description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 11
- 210000001260 vocal cord Anatomy 0.000 abstract description 9
- 239000000126 substance Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 4
- 206010041235 Snoring Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- -1 glycerin fatty acid ester Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960004747 ubidecarenone Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
【解決手段】コエンザイムQ10が発声改良に有効であることを見出し、本発明を完成した。具体的には、コエンザイムQ10あるいはコエンザイムQ10とビタミンEとを主成分とする剤を経口投与することにより、声が良く出るようになり、長時間歌えるようになり、また高音域や低音域が延びるという効果も奏する。
【選択図】 なし
Description
(1) コエンザイムQ10を主成分とする発声改良剤、
(2) コエンザイムQ10及びビタミンEを主成分とする発声改良剤、
(3) コエンザイムQ10を経口投与することを特徴とする発声改良方法、
(4) コエンザイムQ10及びビタミンEを主成分とする製剤を経口投与することを特徴とする発声改良方法
に関する。
製剤方法は、コエンザイムQ10とビタミンEとグリセリン脂肪酸エステル他の成分を60℃程度に加温して混合することにより、製造することができる。これをソフトカプセルあるいはハードカプセルに充填する。
Claims (4)
- コエンザイムQ10を主成分とする発声改良剤。
- コエンザイムQ10及びビタミンEを主成分とする発声改良剤。
- コエンザイムQ10を経口投与することを特徴とする発声改良法。
- コエンザイムQ10及びビタミンEを主成分とする製剤を経口投与することを特徴とする発声改良法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006025924A JP4887052B2 (ja) | 2006-02-02 | 2006-02-02 | 発声改良剤および発声改良方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006025924A JP4887052B2 (ja) | 2006-02-02 | 2006-02-02 | 発声改良剤および発声改良方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007204436A true JP2007204436A (ja) | 2007-08-16 |
JP4887052B2 JP4887052B2 (ja) | 2012-02-29 |
Family
ID=38484209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006025924A Active JP4887052B2 (ja) | 2006-02-02 | 2006-02-02 | 発声改良剤および発声改良方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4887052B2 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009227625A (ja) * | 2008-03-25 | 2009-10-08 | Immudyne Inc | 発声改善剤 |
ITMI20102100A1 (it) * | 2010-11-12 | 2012-05-13 | Scharper Therapeutics Srl | Composizione per il trattamento di disfunzioni degli apparati fonatorio ed olfattorio |
ITMI20120510A1 (it) * | 2012-03-29 | 2013-09-30 | Bio Lo Ga Srl | Vitamina e e suoi esteri per l'uso nel trattamento topico di affezioni faringo-laringee |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07278002A (ja) * | 1994-04-12 | 1995-10-24 | Taisho Pharmaceut Co Ltd | 滋養強壮剤 |
JP2005035918A (ja) * | 2003-07-18 | 2005-02-10 | Yakken:Kk | いびき防止剤 |
JP2005120061A (ja) * | 2003-10-20 | 2005-05-12 | Sanei Gen Ffi Inc | 発声向上剤 |
JP2005239701A (ja) * | 2004-01-26 | 2005-09-08 | Sanei Gen Ffi Inc | 発声向上剤 |
-
2006
- 2006-02-02 JP JP2006025924A patent/JP4887052B2/ja active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07278002A (ja) * | 1994-04-12 | 1995-10-24 | Taisho Pharmaceut Co Ltd | 滋養強壮剤 |
JP2005035918A (ja) * | 2003-07-18 | 2005-02-10 | Yakken:Kk | いびき防止剤 |
JP2005120061A (ja) * | 2003-10-20 | 2005-05-12 | Sanei Gen Ffi Inc | 発声向上剤 |
JP2005239701A (ja) * | 2004-01-26 | 2005-09-08 | Sanei Gen Ffi Inc | 発声向上剤 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009227625A (ja) * | 2008-03-25 | 2009-10-08 | Immudyne Inc | 発声改善剤 |
ITMI20102100A1 (it) * | 2010-11-12 | 2012-05-13 | Scharper Therapeutics Srl | Composizione per il trattamento di disfunzioni degli apparati fonatorio ed olfattorio |
WO2012063217A1 (en) * | 2010-11-12 | 2012-05-18 | Scharper Therapeutics S.R.L | Composition for treating phonatory and olfactory apparatus disorders |
ITMI20120510A1 (it) * | 2012-03-29 | 2013-09-30 | Bio Lo Ga Srl | Vitamina e e suoi esteri per l'uso nel trattamento topico di affezioni faringo-laringee |
Also Published As
Publication number | Publication date |
---|---|
JP4887052B2 (ja) | 2012-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6491189B2 (ja) | 高められ且つ継続されるケトーシスを生じさせる、食欲抑制用、減量促進用、または肥満治療用の組成物および方法 | |
JP5902148B2 (ja) | 自閉症治療用ジメチルスルホキシド(dmso)製剤 | |
JP4887052B2 (ja) | 発声改良剤および発声改良方法 | |
CN103445175B (zh) | 具有解酒保肝作用的组合物 | |
JP4904795B2 (ja) | 疲労改善剤組成物 | |
Askitopoulou et al. | The origins of Oral medicine in the Hippocratic collected works | |
Eskafi | Sleep Apnoea in Patients with Stable Congestive Heart Failure-An Intervention Study with a Mandibular Advancement Device | |
CN1615152A (zh) | 减少痤疮或改善皮色的方法 | |
ATE375146T1 (de) | Schleimdrogenbasierte lutschtablette gegen entzündliche erkrankungen des mund- und rachenraums | |
Sataloff | LaryngoSCOPE: Vocal aging and its medical implications: What singing teachers should know-Part I | |
TW200800161A (en) | Composition for treating chronic obstructive pulmonary disease | |
GB2600668A (en) | Alpha Lipoic Acid (A-ALA) and Alpha Lipoic Acid (R-ALA) As a Pharmaceutical Product for Intravenous Application to reduce Inflammation from infection. | |
JP6153241B2 (ja) | 肝機能障害予防改善剤 | |
Griffith | Remarks on a case of hereditary localized oedema proving fatal by laryngeal obstruction | |
JP2015166328A (ja) | チュアブル錠 | |
CN109864900A (zh) | 牙膏 | |
Sataloff | Vocal aging: Medical considerations in professional voice users | |
Curry et al. | Fundamental frequency characteristics of Japanese Asai speakers | |
DONALDSON et al. | Serotonin and the 5-hydroxyindole pathway of tryptophan metabolism | |
KR100427637B1 (ko) | 세포내 에너지 소비 증가제 | |
Zarnigor | MODERN VIEW ON THE PATHOGENESIS OF PERIODONTITIS | |
Pastorino | Playing with authority: The theatre of Dario Fo (Italy) | |
Inkielewicz-Stępniak et al. | The impact of electronic cigarette liquids on human gingival cell viability–a preliminary in vitro study | |
Handy | COLLECTANEA CLINICA. | |
Ryland | The laryngeal changes induced by mustard-gas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20081008 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111018 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111108 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111129 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111212 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141216 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4887052 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |